In 147 cases of mammary carcinoma, 388 serial mammographies were performed before final treatment. The average retrospective observation time was 27 months with a range of two months to 11 years. The number of serial mammographies per case ranged between two and 11. The tumor volume doubling times (TV); obtained by measuring the growth of the tumor nucleus shadow in the mammographies, ranged from 44 to 1869 days with an average of 212 days. No correlation between volume doubling time and histologic differentiation could be found. One hundred of these cancer patients were found in a screening population of 22,000 women receiving serial mammographies in a time period ranging from two to 16 years. An additional 40 cancer patients surfaced in this group without roentgenologic but with foregoing clinical or thermographic abnormalities before final diagnosis. An additional 21 cancer patients surfaced without any foregoing abnormalities. The follow-up tumor ranged between three months and two years with a mean time of one year and nine months. Not considering tumor size, pathologic-thermographic signs appeared with greater frequency the faster the tumor grew. Theoretically, an average of more than 16 years should elapse before an initial tumor cell develops into a 10-mm primary mammary carcinoma (30 doubling times). Therefore the length of time necessary for a 2-mm tumor to grow to a size of 10-mm is, on the average, four years.

Download full-text PDF

Source
http://dx.doi.org/10.1002/1097-0142(19800415)45:8<2198::aid-cncr2820450832>3.0.co;2-7DOI Listing

Publication Analysis

Top Keywords

serial mammographies
12
cancer patients
12
mammary carcinoma
8
months years
8
volume doubling
8
doubling times
8
additional cancer
8
patients surfaced
8
average years
8
tumor
7

Similar Publications

Article Synopsis
  • Autoimmune diseases can cause rare breast issues, often presenting as lumps or breast pain, and some patients may not show any symptoms at all.
  • The imaging characteristics of autoimmune mastitis are usually nonspecific, often appearing as irregular masses on ultrasounds or segmental enhancements on MRIs, which can make diagnosis difficult.
  • The text highlights a unique case of mastitis linked to Behcet's syndrome, discussing the rapid changes seen in imaging, and reviews existing literature on the radiological and histopathological aspects of autoimmune mastitis.
View Article and Find Full Text PDF

Objective: Changes in a patient's reported breast density status (dense vs nondense) trigger modifications in their cancer risk profile and supplemental screening recommendations. This study tracked the frequency and longitudinal sequence of breast density status changes among patients who received serial mammograms.

Methods: This IRB-approved, HIPAA-compliant retrospective cohort study tracked breast density changes among patients who received at least 2 mammograms over an 8-year study period.

View Article and Find Full Text PDF

Background: To assess if implementation of the 2010 Patient Protection and Affordable Care Act (ACA) was associated with changes in the prevalence of women having ever received a pap smear.

Methods: This study utilised the publicly available Centre for Disease Control National Survey of Family Growth (NSFG) data set. This was a serial cross-sectional study.

View Article and Find Full Text PDF

Background: Tuberculous mastitis (TBM), is an uncommon form of extra-pulmonary tuberculosis. Clinical and radiological overlap of tuberculous mastitis with malignancy and other granulomatous conditions, along with its paucibacillary nature, make it a diagnostic challenge. In our study, we aim to assess the radiological response of microbiologically negative granulomatous mastitis cases to anti-tuberculous treatment (ATT) in an endemic country.

View Article and Find Full Text PDF

Deep learning analysis of serial digital breast tomosynthesis images in a prospective cohort of breast cancer patients who received neoadjuvant chemotherapy.

Eur J Radiol

September 2024

Division of Oncology, Department of Clinical Sciences, Lund University, Sweden; The Department of Clinical Physiology and Nuclear Medicine, Skane University Hospital, Lund, Sweden. Electronic address:

Purpose: Different imaging tools, including digital breast tomosynthesis (DBT), are frequently used for evaluating tumor response during neoadjuvant chemotherapy (NACT). This study aimed to explore whether using artificial intelligence (AI) for serial DBT acquisitions during NACT for breast cancer can predict pathological complete response (pCR) after completion of NACT.

Methods: A total of 149 women (mean age 53 years, pCR rate 22 %) with breast cancer treated with NACT at Skane University Hospital, Sweden, between 2014 and 2019, were prospectively included in this observational cohort study (ClinicalTrials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!